StockNews.com Begins Coverage on Applied DNA Sciences (NASDAQ:APDN)

StockNews.com assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research report sent to investors on Saturday. The firm issued a sell rating on the technology company’s stock.

Separately, HC Wainwright decreased their price objective on Applied DNA Sciences from $7.00 to $1.50 and set a buy rating for the company in a report on Monday, June 10th.

Applied DNA Sciences Stock Performance

Shares of APDN stock opened at $0.55 on Friday. The company has a market cap of $534,100.00, a P/E ratio of -0.03 and a beta of 0.09. The stock has a 50 day simple moving average of $1.94 and a two-hundred day simple moving average of $7.72. Applied DNA Sciences has a fifty-two week low of $0.37 and a fifty-two week high of $37.20.

Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) EPS for the quarter, missing the consensus estimate of ($4.60) by ($0.71). The firm had revenue of $0.93 million for the quarter, compared to the consensus estimate of $0.90 million. Applied DNA Sciences had a negative net margin of 222.33% and a negative return on equity of 306.32%. On average, research analysts predict that Applied DNA Sciences will post -2.95 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences as of its most recent SEC filing. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.